These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1098 related articles for article (PubMed ID: 20180658)

  • 21. Fast-dissolving mucoadhesive microparticulate delivery system containing piroxicam.
    Cilurzo F; Selmin F; Minghetti P; Rimoldi I; Demartin F; Montanari L
    Eur J Pharm Sci; 2005 Mar; 24(4):355-61. PubMed ID: 15734302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dissolution, bioavailability and ulcerogenic studies on piroxicam-nicotinamide solid dispersion formulations.
    Verma MM; Kumar MT; Balasubramaniam J; Pandit JK
    Boll Chim Farm; 2003 Apr; 142(3):119-24. PubMed ID: 12806831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of spray-dried co-precipitate of amorphous celecoxib containing storage and compression stabilizers.
    Dhumal RS; Shimpi SL; Paradkar AR
    Acta Pharm; 2007 Sep; 57(3):287-300. PubMed ID: 17878109
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced dissolution rate of simvastatin using spherical crystallization technique.
    Varshosaz J; Tavakoli N; Salamat FA
    Pharm Dev Technol; 2011 Oct; 16(5):529-35. PubMed ID: 20684739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Properties of melt extruded enteric matrix pellets.
    Schilling SU; Shah NH; Waseem Malick A; McGinity JW
    Eur J Pharm Biopharm; 2010 Feb; 74(2):352-61. PubMed ID: 19782133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New solid lipid microparticles for controlled ibuprofen release: formulation and characterization study.
    Perge L; Robitzer M; Guillemot C; Devoisselle JM; Quignard F; Legrand P
    Int J Pharm; 2012 Jan; 422(1-2):59-67. PubMed ID: 22027394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of two polymorphs of lornoxicam.
    Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S
    J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of azithromycin--Aerosil 200 solid dispersions with enhanced physical stability.
    Li X; Peng H; Tian B; Gou J; Yao Q; Tao X; He H; Zhang Y; Tang X; Cai C
    Int J Pharm; 2015; 486(1-2):175-84. PubMed ID: 25794608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved solubility and dissolution rate of piroxicam using gelucire 44/14 and labrasol.
    Karataş A; Yüksel N; Baykara T
    Farmaco; 2005 Sep; 60(9):777-82. PubMed ID: 16084514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling.
    Naelapää K; Boetker JP; Veski P; Rantanen J; Rades T; Kogermann K
    Int J Pharm; 2012 Jun; 429(1-2):69-77. PubMed ID: 22433471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Solid dispersion of spironolactone with porous silica prepared by the solvent method.
    Uchino T; Yasuno N; Yanagihara Y; Suzuki H
    Pharmazie; 2007 Aug; 62(8):599-603. PubMed ID: 17867555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique.
    Jelvehgari M; Barar J; Valizadeh H; Shadrou S; Nokhodchi A
    Pharm Dev Technol; 2011; 16(6):637-44. PubMed ID: 20722498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S; de Matas M; York P; Saunders M; Sulaiman B
    Int J Pharm; 2011 Aug; 415(1-2):307-14. PubMed ID: 21683776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the solid-dispersion method on the solubility and crystalline property of tacrolimus.
    Joe JH; Lee WM; Park YJ; Joe KH; Oh DH; Seo YG; Woo JS; Yong CS; Choi HG
    Int J Pharm; 2010 Aug; 395(1-2):161-6. PubMed ID: 20580799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nanostructured microspheres produced by supercritical fluid extraction of emulsions.
    Della Porta G; Reverchon E
    Biotechnol Bioeng; 2008 Aug; 100(5):1020-33. PubMed ID: 18383122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Eudragit S-100 coated sodium alginate microspheres of naproxen sodium: formulation, optimization and in vitro evaluation.
    Chawla A; Sharma P; Pawar P
    Acta Pharm; 2012 Dec; 62(4):529-45. PubMed ID: 23333888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
    Lai F; Pini E; Angioni G; Manca ML; Perricci J; Sinico C; Fadda AM
    Eur J Pharm Biopharm; 2011 Nov; 79(3):552-8. PubMed ID: 21820052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Poloxamer 407 microspheres for orotransmucosal drug delivery. Part I: formulation, manufacturing and characterization.
    Albertini B; Passerini N; Di Sabatino M; Monti D; Burgalassi S; Chetoni P; Rodriguez L
    Int J Pharm; 2010 Oct; 399(1-2):71-9. PubMed ID: 20696227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug release characteristics from nanoclay hybrids and their dispersions in organic polymers.
    Ha JU; Xanthos M
    Int J Pharm; 2011 Jul; 414(1-2):321-31. PubMed ID: 21601624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 55.